Terms: = Germ cell tumor AND KMT2A, TRX1, 4297, MLL, ENSG00000118058, MLL/GAS7, HTRX1, HRX, ALL-1, MLL1A, CXXC7
95 results:
1. [Clinical analysis of 12 cases of ovarian yolk sac tumor].
Liu J; Chu HJ; Shan YP; Song WJ; Chen AP
Zhonghua Fu Chan Ke Za Zhi; 2024 Mar; 59(3):210-214. PubMed ID: 38544450
[No Abstract] [Full Text] [Related]
2. Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survival.
Ozyerli-Goknar E; Kala EY; Aksu AC; Bulut I; Cingöz A; Nizamuddin S; Biniossek M; Seker-Polat F; Morova T; Aztekin C; Kung SHY; Syed H; Tuncbag N; Gönen M; Philpott M; Cribbs AP; Acilan C; Lack NA; Onder TT; Timmers HTM; Bagci-Onder T
Cell Commun Signal; 2023 Nov; 21(1):328. PubMed ID: 37974198
[TBL] [Abstract] [Full Text] [Related]
3. Association of the Genomic Profile of Medullary Thyroid Carcinoma with tumor Characteristics and Clinical Outcomes in an International Multicenter Study.
Xu B; Viswanathan K; Ahadi MS; Ahmadi S; Alzumaili B; Bani MA; Baudin E; Behrman DB; Capelletti M; Chau NG; Chiarucci F; Chou A; Clifton-Bligh R; Coluccelli S; de Biase D; De Leo A; Dogan S; Fagin JA; Fuchs TL; Glover AR; Hadoux J; Lacroix L; Lamartina L; Lubin DJ; Luxford C; Magliocca K; Maloberti T; Mohanty AS; Najdawi F; Nigam A; Papachristos AJ; Repaci A; Robinson B; Scoazec JY; Shi Q; Sidhu S; Solaroli E; Sywak M; Tuttle RM; Untch B; Barletta JA; Al Ghuzlan A; Gill AJ; Ghossein R; Tallini G; Ganly I
Thyroid; 2024 Feb; 34(2):167-176. PubMed ID: 37842841
[No Abstract] [Full Text] [Related]
4. Nanoparticles Hitchhike on Monocytes for Glioblastoma Treatment after Low-Dose Radiotherapy.
Kuang J; Rao ZY; Zheng DW; Kuang D; Huang QX; Pan T; Li H; Zeng X; Zhang XZ
ACS Nano; 2023 Jul; 17(14):13333-13347. PubMed ID: 37404077
[TBL] [Abstract] [Full Text] [Related]
5. PATH-SURVEYOR: pathway level survival enquiry for immuno-oncology and drug repurposing.
Obermayer AN; Chang D; Nobles G; Teng M; Tan AC; Wang X; Chen YA; Eschrich S; Rodriguez PC; Grass GD; Meshinchi S; Tarhini A; Chen DT; Shaw TI
BMC Bioinformatics; 2023 Jun; 24(1):266. PubMed ID: 37380943
[TBL] [Abstract] [Full Text] [Related]
6. Health-related quality of life and cognitive failures in patients with lower-grade gliomas treated with radiotherapy.
Di Perri D; Jmil S; Lawson TM; Van Calster L; Whenham N; Renard L
Cancer Radiother; 2023 May; 27(3):219-224. PubMed ID: 37080857
[TBL] [Abstract] [Full Text] [Related]
7. Downregulation of BASP1 Promotes Temozolomide Resistance in Gliomas via Epigenetic Activation of the FBXO32/NF-κB/MGMT Axis.
Liao X; Li Z; Zheng H; Qian W; Zhang S; Chen S; Li X; Tang M; Xu Y; Yu R; Li M; Song L; Li J
Mol Cancer Res; 2023 Jul; 21(7):648-663. PubMed ID: 36961398
[TBL] [Abstract] [Full Text] [Related]
8. A secondary CD34+ acute lymphoblastic leukemia unmasked and mobilized by G-CSF in an autologous stem cell donor with testicular cancer.
Cooling L; Kelley J; Sexton E; Anand S; Hoffmann S
Transfusion; 2023 Apr; 63(4):684-689. PubMed ID: 36762622
[TBL] [Abstract] [Full Text] [Related]
9. Gene fusions are frequent in ACTH-secreting neuroendocrine neoplasms of the pancreas, but not in their non-pancreatic counterparts.
Agaimy A; Kasajima A; Stoehr R; Haller F; Schubart C; Tögel L; Pfarr N; von Werder A; Pavel ME; Sessa F; Uccella S; La Rosa S; Klöppel G
Virchows Arch; 2023 Mar; 482(3):507-516. PubMed ID: 36690805
[TBL] [Abstract] [Full Text] [Related]
10. FOXQ1 recruits the mll complex to activate transcription of EMT and promote breast cancer metastasis.
Mitchell AV; Wu L; James Block C; Zhang M; Hackett J; Craig DB; Chen W; Zhao Y; Zhang B; Dang Y; Zhang X; Zhang S; Wang C; Gibson H; Pile LA; Kidder B; Matherly L; Yang Z; Dou Y; Wu G
Nat Commun; 2022 Nov; 13(1):6548. PubMed ID: 36319643
[TBL] [Abstract] [Full Text] [Related]
11. Diallyl trisulfide sensitizes radiation therapy on glioblastoma through directly targeting thioredoxin 1.
Tian Y; Ge Z; Xu M; Ge X; Zhao M; Ding F; Yin J; Wang X; You Y; Shi Z; Qian X
Free Radic Biol Med; 2022 Aug; 189():157-168. PubMed ID: 35921994
[TBL] [Abstract] [Full Text] [Related]
12. Endolysosome Iron Chelation Inhibits HIV-1 Protein-Induced Endolysosome De-Acidification-Induced Increases in Mitochondrial Fragmentation, Mitophagy, and cell Death.
Halcrow PW; Kumar N; Quansah DNK; Baral A; Liang B; Geiger JD
Cells; 2022 May; 11(11):. PubMed ID: 35681506
[TBL] [Abstract] [Full Text] [Related]
13. Molecular deciphering of primary liver neuroendocrine neoplasms confirms their distinct existence with foregut-like profile.
de Mestier L; Nicolle R; Poté N; Rebours V; Cauchy F; Hentic O; Maire F; Ronot M; Lebtahi R; Sauvanet A; Paradis V; Ruszniewski P; Couvelard A; Cros J
J Pathol; 2022 Sep; 258(1):58-68. PubMed ID: 35681273
[TBL] [Abstract] [Full Text] [Related]
14.
Forgione MO; McClure BJ; Page EC; Yeung DT; Eadie LN; White DL
Oncol Rep; 2022 May; 47(5):. PubMed ID: 35323988
[TBL] [Abstract] [Full Text] [Related]
15. Combining hyperintense FLAIR rim and radiological features in identifying IDH mutant 1p/19q non-codeleted lower-grade glioma.
Li M; Ren X; Chen X; Wang J; Shen S; Jiang H; Yang C; Zhao X; Zhu Q; Cui Y; Lin S
Eur Radiol; 2022 Jun; 32(6):3869-3879. PubMed ID: 35079884
[TBL] [Abstract] [Full Text] [Related]
16. Bone Marrow Surveillance of Pediatric Cancer Survivors Identifies Clones that Predict Therapy-Related Leukemia.
Spitzer B; Rutherford KD; Gundem G; McGovern EM; Millard NE; Arango Ossa JE; Cheung IY; Gao T; Levine MF; Zhang Y; Medina-Martínez JS; Feng Y; Ptashkin RN; Bolton KL; Farnoud N; Zhou Y; Patel MA; Asimomitis G; Cobbs CC; Mohibullah N; Huberman KH; Arcilla ME; Kushner BH; Modak S; Kung AL; Zehir A; Levine RL; Armstrong SA; Cheung NKV; Papaemmanuil E
Clin Cancer Res; 2022 Apr; 28(8):1614-1627. PubMed ID: 35078859
[TBL] [Abstract] [Full Text] [Related]
17. Sex Differences in Cutaneous Melanoma: Incidence, Clinicopathological Profile, Survival, and Costs.
Buja A; Rugge M; Damiani G; Zorzi M; De Toni C; Vecchiato A; Del Fiore P; Spina R; Baldo V; Brazzale AR; Rossi CR; Mocellin S
J Womens Health (Larchmt); 2022 Jul; 31(7):1012-1019. PubMed ID: 35076310
[No Abstract] [Full Text] [Related]
18. Glioblastoma stem cells reprogram chromatin in vivo to generate selective therapeutic dependencies on DPY30 and phosphodiesterases.
Dixit D; Prager BC; Gimple RC; Miller TE; Wu Q; Yomtoubian S; Kidwell RL; Lv D; Zhao L; Qiu Z; Zhang G; Lee D; Park DE; Wechsler-Reya RJ; Wang X; Bao S; Rich JN
Sci Transl Med; 2022 Jan; 14(626):eabf3917. PubMed ID: 34985972
[TBL] [Abstract] [Full Text] [Related]
19. Thioredoxin-1 mediates neuroprotection of Schisanhenol against MPP
Yang H; Li L; Jiao Y; Zhang Y; Wang Y; Zhu K; Sun C
Sci Rep; 2021 Nov; 11(1):21604. PubMed ID: 34732784
[TBL] [Abstract] [Full Text] [Related]
20. kmt2a-MAML2 rearrangement emerged and regressed during neuroblastoma therapy without leukemia after 12.8-year follow-up.
Felix CA; Slater DJ; Davenport JW; Yu X; Gregory BD; Li MM; Rappaport EF; Cheung NV
Pediatr Blood Cancer; 2022 Jan; 69(1):e29344. PubMed ID: 34550633
[TBL] [Abstract] [Full Text] [Related]
[Next]